Pricing Log in Create free account

Editas Medicine, Inc. (EDIT) vs Tectonic Therapeutic, Inc. (TECX)

Editas Medicine, Inc. and Tectonic Therapeutic, Inc. are both Biotechnology companies. Editas Medicine, Inc. and Tectonic Therapeutic, Inc. are of similar size ($456.1M and $445.4M). Tectonic Therapeutic, Inc. has the higher net margin (0.00% vs −157.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Tectonic Therapeutic, Inc. leads on 10 and Editas Medicine, Inc. on 2.

Valuation

Metric EDIT TECX Biotechnology median
P/E n/m n/m 8.56
P/S 6.98 n/m 10.17
P/B 3.12 1.89 2.34
Price to free cash flow n/m n/m 20.42
EV/EBITDA n/m n/m 0.69
EV/Sales 3.17 n/m 9.64
Earnings yield (27.27%) (20.45%) (29.41%)
Free cash flow yield (36.66%) (17.08%) (23.50%)

Profitability

Metric EDIT TECX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (161.39%) 0.00% 0.00%
Net margin (157.32%) 0.00% 0.00%
Free cash flow margin (255.88%) 0.00% 0.00%
Return on equity (118.82%) (33.80%) (56.66%)
Return on assets (33.02%) (32.23%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EDIT TECX Biotechnology median
Revenue growth (TTM) 20.83% — 5.64%
EPS growth (last fiscal year) 37.50% 40.70% 30.08%
Revenue growth, 5-year CAGR (14.89%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EDIT TECX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.19 22.29 4.72
Net debt to EBITDA 0.94 3.08 0.96

Dividend

Metric EDIT TECX Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric EDIT TECX Biotechnology median
Market cap 445.38m 456.09m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack